Anand Kapila K 4
4 · Elanco Animal Health Inc · Filed Jul 5, 2023
Insider Transaction Report
Form 4
Anand Kapila K
Director
Transactions
- Award
Deferred Stock Units
2023-03-31$9.40/sh+1,529.255$14,375→ 2,987.332 total→ Common Stock (1,529.255 underlying) - Award
Deferred Stock Units
2023-06-30$10.06/sh+1,428.926$14,375→ 4,416.258 total→ Common Stock (1,428.926 underlying)
Footnotes (4)
- [F1]Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
- [F2]The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
- [F3]The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $9.40 on March 31, 2023.
- [F4]The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $10.06 on June 30, 2023.